| 3PM London / 10AM New York
Saudi Arabia – A Vital Middle East Hub for Clinical Trials
What makes Saudi Arabia the go-to location for clinical research and how trusted, local expertise can help overcome key barriers.
| 3PM London / 10AM New York
The emerging AI decision in clinical trials: controlled vs. open framework
| 3PM London / 10AM New York
Before the First Dose: Building a Phase I Strategy That Supports the Next Development Decision focused
Challenges and benefits when considering digital components within study protocols
